Skip to main content

Ethicon Physiomesh Trials To Begin From March

Ethicon Physiomesh Trials To Begin From March

Ethicon Physiomesh Trials To Begin From March

Introduction

U.S. District Judge Richard Story, presiding over all federal hernia mesh lawsuits involving Ethicon Physiomesh, has released a trial schedule with the first case starting in March.

Johnson & Johnson’s Ethicon subsidiary introduced the Ethicon Physiomesh in 2010. It was a multi-layered, flexible composite hernia mesh product that was removed from the market after six years of its launch. The discontinuation of the product resulted from numerous complaints that claimed additional surgeries for the individuals who had it implanted.

Currently, more than 3,000 Ethicon Physiomesh lawsuits are filed throughout the federal system. Each lawsuit claims that the manufacturer sold an unreasonably dangerous and defective product that resulted in painful and debilitating complications causing severe abdominal pain, infection, hernia recurrence, adhesions, perforations, erosion, and other injuries leading to revision surgery for removal of the product.

The lawsuits are consolidated under MDL No.: 2782 in the Northern District of Georgia. The jury has identified four cases that will go before trial for the hearings starting from March 18, 2021. The initial trial is estimated to go on for two to three weeks, followed by the second trial set to begin on June 7, 2021. The remaining two trials will go before the jury on September 13, 2021. 

As a part of an MDL or multidistrict litigation, all the federal cases are centralized before U.S. District Judge Richard Story in the Northern District of Georgia to reach a common outcome.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!